Experience

INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS

• France
• Research Services
• 1 - 100 Employee

• Senior Clinical Scientist

  • Sep 2009 - Present

  Senior Clinical Scientist in oncology R&D. I have been working as clinical scientist in the clinical development of: - Targeted therapies : HDAC inhibitors, BCL2 inhibitors, MAT2A inhibitors - Allogeneic CAR-T cell therapy (3 years) - chemotherpay : Pixantrone I designed and wrote several phase I/II protocols in solid tumors ( breast, ovarian, esophagus) and haematological tumors (ALL, AML, NHL) I've been involved in several clinical discussion with investigators (end of cohort meetings, boards, clinical discussion on patients...). I was co-author of a publication in the Lancet : Lancet 2020, 396:1885-1894 Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

• Senior Clinical Project Manager

  • Jul 2001 - Jun 2009

  Clinical Project manager in Cardiovascular and Internal medecine R&D Clinical Project manager in Cardiovascular and Internal medecine R&D